Anti-infective and anti-inflammatory treatment strategies for Mycoplasma pneumoniae pneumonia
10.3760/cma.j.issn.1673-4408.2024.12.008
- VernacularTitle:肺炎支原体肺炎的抗感染与抗炎治疗研究进展
- Author:
Ping CHENG
1
;
Yuanyuan ZHANG
;
Zhimin CHEN
Author Information
1. 三门县人民医院儿科，台州 317100
- Keywords:
Mycoplasma Pneumoniae;
Pneumonia;
Anti-infective drugs;
Glucocorticoid;
Child
- From:
International Journal of Pediatrics
2024;51(12):829-833
- CountryChina
- Language:Chinese
-
Abstract:
In recent years，infections caused by macrolide-resistant Mycoplasma pneumoniae（MRMP）have garnered widespread attention.Concurrently，there has been a notable increase in the incidence of severe and refractory Mycoplasma pneumoniae pneumonia（MPP），posing significant challenges to clinical diagnostic and therapeutic practices.The early identification and intervention of severe and critical cases to prevent mortality and sequelae have become a formidable challenge and an important issue for pediatricians.Among these，the judicious application of anti-infective and anti-inflammatory drugs in the early stages is key for improving prognosis.This article aims to provide an review on the anti-infective and anti-inflammatory treatment strategies for MPP.
